Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

In a sign of turnaround, over 200 smallcaps log double-digit weekly gains. Will the momentum continue?

Following a challenging February for smallcap stocks, the first week of March showed signs of recovery with over 200 smallcap names seeing d...